Patrick Neven
Universitair Ziekenhuis Leuven(BE)The European Academy of Gynaecological Surgery(BE)KU Leuven(BE)
Publications by Year
Research Areas
Breast Cancer Treatment Studies, Advanced Breast Cancer Therapies, Estrogen and related hormone effects, HER2/EGFR in Cancer Research, Cancer Treatment and Pharmacology
Most-Cited Works
- → MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2− Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy(2017)1,620 cited
- → Endometrial cancer(2005)1,505 cited
- → Phase III Randomized Study of Ribociclib and Fulvestrant in Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: MONALEESA-3(2018)1,086 cited
- → The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor–Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy—MONARCH 2(2019)960 cited
- → A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer(2021)865 cited
- → Overall Survival with Ribociclib plus Fulvestrant in Advanced Breast Cancer(2019)821 cited